APA (7th ed.) Citation

Daneels, W., Van Parys, A., Huyghe, L., Rogge, E., De Rouck, S., Christiaen, R., . . . Offner, F. (2024). High efficacy of huCD20-targeted AcTaferon in humanized patient derived xenograft models of aggressive B cell lymphoma. Experimental Hematology & Oncology, 13(1), 1. https://doi.org/10.1186/s40164-024-00524-4

Chicago Style (17th ed.) Citation

Daneels, Willem, et al. "High Efficacy of HuCD20-targeted AcTaferon in Humanized Patient Derived Xenograft Models of Aggressive B Cell Lymphoma." Experimental Hematology & Oncology 13, no. 1 (2024): 1. https://doi.org/10.1186/s40164-024-00524-4.

MLA (9th ed.) Citation

Daneels, Willem, et al. "High Efficacy of HuCD20-targeted AcTaferon in Humanized Patient Derived Xenograft Models of Aggressive B Cell Lymphoma." Experimental Hematology & Oncology, vol. 13, no. 1, 2024, p. 1, https://doi.org/10.1186/s40164-024-00524-4.